Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway.

Journal of clinical lipidology - 1 Jan 2000

Leren Trond P, Bogsrud Martin Prøven

Abstract excerpt

BACKGROUND: The most cost-effective strategy to diagnose patients with autosomal dominant hypercholesterolemia (ADH) is to perform cascade genetic screening. OBJECTIVE: To present the cascade genetic screening program for ADH in Norway. METHODS: A national cascade genetic screening program for ADH in Norway has been operating at Unit for Cardiac and Cardiovascular Genetics, Oslo University Hospital for twenty...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholesterol, LDL
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genes, Dominant

Share to Hypercholesterolemia

Share to Mass Screening

Share to National Health Programs

Share to Norway

Source

Identifiers

PMID: 34479846
DOI: 10.1016/j.jacl.2021.08.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The importance of cascade genetic screening for diagnosing autosomal dominant hypercholesterolemia: Results from twenty years of a national screening program in Norway.PMID 34479846Read ↗

Cascade screening for familial hypercholesterolemia: Practical consequences.Semantic proximity Read ↗

Molecular genetic testing for autosomal dominant hypercholesterolemia in 29,449 Norwegian index patients and 14,230 relatives during the years 1993-2020.Semantic proximity Read ↗

Cascade screening for familial hypercholesterolemia should be organized at a national level.Semantic proximity Read ↗

Cascade genetic screening for familial hypercholesterolemiaSemantic proximity Read ↗

Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testingSemantic proximity Read ↗

Molecular genetics in 1991 arrhythmia probands and 2782 relatives in Norway: Results from 17 years of genetic testing in a national laboratory.Semantic proximity Read ↗

Cascade genetic counseling and testing in hereditary syndromes: inherited cardiovascular disease as a model: a narrative review.Semantic proximity Read ↗

Feasibility and cost of FH cascade screening in Belgium (BEL-CASCADE) including a novel rapid rule-out strategy.Semantic proximity Read ↗

Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.Semantic proximity Read ↗

[Digiphysical cascade screening model to diagnose familial hypercholesterolemia in relatives to an index case].Semantic proximity Read ↗

Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.Semantic proximity Read ↗

Application of molecular genetics for diagnosing familial hypercholesterolemia in Norway: results from a family-based screening program.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.